Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S K Grebe

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Surgical Oncology Clinics of North America|January 1, 1996
Thyroid cancer nodal metastases: biologic significance and therapeutic considerationsS K Grebe, I D Hay
The New Zealand Medical Journal|August 25, 1995
Clinical audit and standardised follow up improve quality of documentation in diabetes careS K Grebe, R B Smith
The Western Journal of Medicine|September 1, 1996
Prognostic factors and management in thyroid cancer--consensus or controversy?S K Grebe, I D Hay
Journal of Endocrinological Investigation|January 1, 1997
The role of surgery in the management of differentiated thyroid cancerS K Grebe, I D Hay
Endocrinology and Metabolism Clinics of North America|December 1, 1995
Follicular thyroid cancerS K Grebe, I D Hay
Cancer Treatment and Research|January 1, 1997
Follicular cell-derived thyroid carcinomasS K Grebe, I D Hay
Expert Review of Anticancer Therapy|July 13, 2002
Evolving classification of renal cell neoplasiaB Delahunt, M Velickovic, S K Grebe
Cancer Research|March 30, 1999
Loss of heterozygosity at 3p14.2 in clear cell renal cell carcinoma is an early event and is highly localized to the FHIT gene locusM Velickovic, B Delahunt, S K Grebe
Biotechniques|October 19, 1999
Increasing sample throughput on a standard 36-lane model 377 DNA sequencer to 48 or 64 samples per runZ M Velickovic, M B Velickovic, S K Grebe
The New Zealand Medical Journal|April 8, 1992
Treatment of extensively invasive (giant) prolactinomas with bromocriptineS K Grebe, J W Delahunt, C M Feek
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Surgical Oncology Clinics of North America|January 1, 1996
Thyroid cancer nodal metastases: biologic significance and therapeutic considerationsS K Grebe, I D Hay
The New Zealand Medical Journal|August 25, 1995
Clinical audit and standardised follow up improve quality of documentation in diabetes careS K Grebe, R B Smith
The Western Journal of Medicine|September 1, 1996
Prognostic factors and management in thyroid cancer--consensus or controversy?S K Grebe, I D Hay
Journal of Endocrinological Investigation|January 1, 1997
The role of surgery in the management of differentiated thyroid cancerS K Grebe, I D Hay
Endocrinology and Metabolism Clinics of North America|December 1, 1995
Follicular thyroid cancerS K Grebe, I D Hay
Cancer Treatment and Research|January 1, 1997
Follicular cell-derived thyroid carcinomasS K Grebe, I D Hay
Expert Review of Anticancer Therapy|July 13, 2002
Evolving classification of renal cell neoplasiaB Delahunt, M Velickovic, S K Grebe
Cancer Research|March 30, 1999
Loss of heterozygosity at 3p14.2 in clear cell renal cell carcinoma is an early event and is highly localized to the FHIT gene locusM Velickovic, B Delahunt, S K Grebe
Biotechniques|October 19, 1999
Increasing sample throughput on a standard 36-lane model 377 DNA sequencer to 48 or 64 samples per runZ M Velickovic, M B Velickovic, S K Grebe
The New Zealand Medical Journal|April 8, 1992
Treatment of extensively invasive (giant) prolactinomas with bromocriptineS K Grebe, J W Delahunt, C M Feek
Pageof 3